Available:*
Library | Item Barcode | Call Number | Material Type | Item Category 1 | Status |
---|---|---|---|---|---|
Searching... | 30000010167833 | RC267 A66 2007 | Open Access Book | Book | Searching... |
On Order
Summary
Summary
Apoptosis, Senescence and Cancer provides insight into established practices and research into apoptosis and senescence by thoroughly examining novel and emerging techniques and research in the fields of cell death pathways, senescence growth arrest, drugs and resistance, DNA damage response, and other topics which still hold mysteries for researchers.
The volume is divided into six easy to follow sections. The first is Apoptosis and Alternative Modes of Cell Death, followed by chapters on Telomeres and Telomerase, Senescence, Genomic Instability and Tumorigenesis. The third part covers DNA Damage Response, Signaling Pathways and Tumorigenesis, while the fourth delves into Resistance and Sensitization. The book concludes with Established Cancer Therapies and a section which looks toward the future with Recent and Developing Cancer Therapies.
In total, this volume provides basic scientists and clinicians with a deeper and more complete understanding of the cellular responses of malignancies which may determine the effectiveness of treatment, both in the initial stages of the disease as well as in disease recurrence.
Author Notes
Lisa M. Greenhill is the Associate Executive Director for Institutional Research and Diversity for the Association of American Veterinary Medical Colleges. Her work primarily focuses on the ongoing development and implementation of the DVM: DiVersity Matters initiative at the national and local levels as well as promoting the veterinary medical profession within communities of color. Greenhill is the recipient of the Emerging Leader Award from the National Association of Minority Medical Educators, Inc.
Kauline Cipriani Davis is the Director of Diversity Initiatives at the Purdue School of Veterinary Medicine. She is responsible for developing, implementing and coordinating initiatives to enhance diversity and inclusiveness.
Patricia M. Lowrie is the Assistant to the Dean in the College of Veterinary Medicine and is also the Director of the Women's Resource Center at Michigan State University. She is the recipient of the MSU University Diversity Award, and she was recently recognized by the Association of American Veterinary Colleges for her contributions to veterinary medical education. Lowrie currently is a senior fellow at the Association of American Colleges and Universities and serves as chairperson of the advisory board for Campus Women Lead.
Sandra F. Amass is the Associate Dean for Engagement and a professor of veterinary clinical sciences at the Purdue School of Veterinary Medicine. She is a co-PI on the Fat Dogs and Coughing Horses Program, a cooperative effort funded by NIH/NCRR/SEPA to develop educational programs for P-12 students.
Table of Contents
Preface | p. v |
Contributors | p. xi |
Introduction and Overview | p. xv |
Part I Apoptosis and Alternative Modes of Cell Death | |
1 The Intrinsic Pathway of Apoptosis | p. 3 |
2 The Extrinsic Pathway of Apoptosis | p. 31 |
3 Evaluating the Importance of Apoptosis and Other Determinants of Cell Death and Survival | p. 55 |
4 Mitotic Catastrophe | p. 73 |
5 Autophagy and Autophagic Cell Death | p. 93 |
6 Regulation and Function of Detachment-Induced Cell Death (Anoikis) in Cancer Progression and Metastasis | p. 109 |
Part II Telomeres and Telomerase, Senescence, Genomic Instability, and Tumorigenesis | |
7 Structure and Function of the Telomere | p. 125 |
8 Overview of Senescence | p. 145 |
9 Contributions of Telomerase to Tumorigenesis | p. 159 |
10 The Role of Telomeres in Genomic Instability | p. 173 |
Part III DNA Damage Response, Signaling Pathways, and Tumorigenesis | |
11 Overview of the DNA Damage Checkpoint: ATM and ATR | p. 193 |
12 Interactions Between Myc- and Cyclin-Dependent Kinase Inhibitors in Cancer | p. 223 |
13 Interplay Between [gamma]H2AX and 53BP1 Pathways in DNA Double-Strand Break Repair Response | p. 243 |
14 DNA-Dependent Protein Kinase in Repair, Apoptosis, Telomere Maintenance, and Chemotherapy | p. 265 |
Part IV Resistance and Sensitization | |
15 Resistance/Signaling Pathways | p. 281 |
16 Ceramide and Multidrug Resistance | p. 299 |
17 Chemo- and Radiosensitization Through Inhibition of PI3K/Akt Signaling | p. 313 |
18 The Advancement of Epidermal Growth Factor Receptor Inhibitors in Cancer Therapy | p. 335 |
Part V Established Cancer Therapies | |
19 Antimetabolites | p. 361 |
20 Topoisomerase I Poisons and Apoptotic Topoisomerase I-DNA Complexe | p. 383 |
21 Perturbations of Cellular Functions by Topoisomerase II Inhibitors: All Roads Lead to Cell Death? | p. 407 |
22 The Significance of Poly-Targeting in Apoptosis Induction by Alkylating Agents and Platinum Drugs | p. 423 |
23 Contributions of Apoptosis and Senescence to Cytotoxicity Produced by Microtubule-Stabilizing Agents | p. 465 |
24 Tyrosine Kinase Inhibitors | p. 477 |
Part VI Recent and Developing Cancer Therapies | |
25 Monoclonal Antibodies in Lymphomas | p. 511 |
26 Role of Apoptosis in Anti-Angiogenic Cancer Therapies | p. 537 |
27 Photodynamic Therapy-Induced Apoptosis | p. 557 |
28 Modulation of TRAIL Signaling for Cancer Therapy | p. 579 |
Index | p. 593 |